Analysts’ price target changes for Monday, June 8th:
ABM Industries (NYSE:ABM) had its price target boosted by Robert W. Baird from $45.00 to $48.00. The firm currently has a neutral rating on the stock.
Accenture (NYSE:ACN) had its price target cut by JPMorgan Chase & Co. from $247.00 to $201.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
American International Group (NYSE:AIG) had its price target reduced by The Goldman Sachs Group, Inc. from $90.00 to $85.00. The firm currently has a buy rating on the stock.
Allarity Therapeutics (NASDAQ:ALLR) had its price target boosted by Ascendiant Capital Markets from $9.75 to $10.25. The firm currently has a buy rating on the stock.
Arista Networks (NYSE:ANET) had its price target increased by Bank of America Corporation from $185.00 to $200.00. Bank of America Corporation currently has a buy rating on the stock.
Aptiv (NYSE:APTV) had its price target cut by Piper Sandler from $106.00 to $94.00. They currently have an overweight rating on the stock.
ArcBest (NASDAQ:ARCB) had its target price boosted by JPMorgan Chase & Co. from $117.00 to $147.00. The firm currently has a neutral rating on the stock.
Alexandria Real Estate Equities (NYSE:ARE) had its target price increased by Evercore Inc from $55.00 to $58.00. The firm currently has an outperform rating on the stock.
BHP Group (LON:BHP) had its target price boosted by Citigroup Inc. from £290 to £350. Citigroup Inc. currently has a neutral rating on the stock.
BlackRock (NYSE:BLK) had its price target lowered by Evercore Inc from $1,220.00 to $1,140.00. They currently have an outperform rating on the stock.
Bruker (NASDAQ:BRKR) had its price target boosted by JPMorgan Chase & Co. from $55.00 to $65.00. The firm currently has an overweight rating on the stock.
Chubb (NYSE:CB) had its price target lowered by The Goldman Sachs Group, Inc. from $372.00 to $362.00. The firm currently has a buy rating on the stock.
Cigna Group (NYSE:CI) had its target price increased by Mizuho from $330.00 to $340.00. Mizuho currently has an outperform rating on the stock.
Cingulate (NASDAQ:CING) had its price target cut by Ascendiant Capital Markets from $55.00 to $52.00. Ascendiant Capital Markets currently has a buy rating on the stock.
Cleanspark (NASDAQ:CLSK) had its target price boosted by Chardan Capital from $16.00 to $19.00. The firm currently has a buy rating on the stock.
Centene (NYSE:CNC) had its price target raised by JPMorgan Chase & Co. from $52.00 to $60.00. The firm currently has a neutral rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Bank of America Corporation from $135.00 to $150.00. They currently have a buy rating on the stock.
Cognizant Technology Solutions (NASDAQ:CTSH) had its price target raised by Citigroup Inc. from $51.00 to $55.00. Citigroup Inc. currently has a neutral rating on the stock.
CVS Health (NYSE:CVS) had its target price boosted by UBS Group AG from $100.00 to $115.00. UBS Group AG currently has a buy rating on the stock.
Datadog (NASDAQ:DDOG) had its target price raised by Bank of America Corporation from $260.00 to $280.00. The firm currently has a buy rating on the stock.
Domo (NASDAQ:DOMO) had its price target lowered by TD Cowen from $9.00 to $6.00. TD Cowen currently has a buy rating on the stock.
Elevance Health (NYSE:ELV) had its target price boosted by JPMorgan Chase & Co. from $411.00 to $476.00. They currently have an overweight rating on the stock.
Equity Residential (NYSE:EQR) had its target price boosted by Evercore Inc from $70.00 to $71.00.
Equity Residential (NYSE:EQR) had its target price raised by BMO Capital Markets from $68.00 to $75.00. The firm currently has a market perform rating on the stock.
Extreme Networks (NASDAQ:EXTR) had its price target raised by Bank of America Corporation from $28.00 to $33.00. They currently have a buy rating on the stock.
Ford Motor (NYSE:F) had its target price raised by UBS Group AG from $14.00 to $17.00. The firm currently has a buy rating on the stock.
Freeport-McMoRan (NYSE:FCX) had its price target increased by Jefferies Financial Group Inc. from $75.00 to $85.00. They currently have a buy rating on the stock.
JFrog (NASDAQ:FROG) had its price target boosted by Bank of America Corporation from $85.00 to $100.00. The firm currently has a buy rating on the stock.
Fortinet (NASDAQ:FTNT) had its price target boosted by Bank of America Corporation from $130.00 to $180.00. The firm currently has a buy rating on the stock.
Guidewire Software (NYSE:GWRE) had its price target trimmed by DA Davidson from $246.00 to $222.00. They currently have a buy rating on the stock.
Humana (NYSE:HUM) had its price target raised by JPMorgan Chase & Co. from $214.00 to $316.00. They currently have a neutral rating on the stock.
Hyperion DeFi (NASDAQ:HYPD) had its target price cut by Chardan Capital from $8.25 to $7.30. The firm currently has a buy rating on the stock.
IGC Pharma (NYSEAMERICAN:IGC) had its price target boosted by Ascendiant Capital Markets from $5.25 to $5.50. Ascendiant Capital Markets currently has a buy rating on the stock.
Insmed (NASDAQ:INSM) had its target price reduced by JPMorgan Chase & Co. from $180.00 to $179.00. The firm currently has an overweight rating on the stock.
Intrusion (NASDAQ:INTZ) had its price target reduced by Ascendiant Capital Markets from $10.50 to $9.50. The firm currently has a buy rating on the stock.
Lucid Diagnostics (NASDAQ:LUCD) had its target price raised by Ascendiant Capital Markets from $9.00 to $9.25. Ascendiant Capital Markets currently has a buy rating on the stock.
lululemon athletica (NASDAQ:LULU) had its price target cut by Deutsche Bank Aktiengesellschaft from $171.00 to $127.00. The firm currently has a hold rating on the stock.
MongoDB (NASDAQ:MDB) had its price target boosted by Bank of America Corporation from $390.00 to $450.00. The firm currently has a buy rating on the stock.
Molina Healthcare (NYSE:MOH) had its target price boosted by JPMorgan Chase & Co. from $169.00 to $191.00. The firm currently has a neutral rating on the stock.
Moderna (NASDAQ:MRNA) had its target price raised by Bank of America Corporation from $32.00 to $34.00. The firm currently has an underperform rating on the stock.
Micron Technology (NASDAQ:MU) had its price target raised by Cantor Fitzgerald from $700.00 to $1,500.00. They currently have an overweight rating on the stock.
Micron Technology (NASDAQ:MU) had its price target raised by Wells Fargo & Company from $550.00 to $1,220.00. They currently have an overweight rating on the stock.
Myomo (NYSEAMERICAN:MYO) had its target price increased by Ascendiant Capital Markets from $9.50 to $10.00. The firm currently has a buy rating on the stock.
Navan (NASDAQ:NAVN) had its target price boosted by Rosenblatt Securities from $20.00 to $24.00. They currently have a buy rating on the stock.
Nebius Group (NASDAQ:NBIS) had its target price boosted by Bank of America Corporation from $240.00 to $280.00. Bank of America Corporation currently has a buy rating on the stock.
Newmont (NYSE:NEM) had its target price increased by Jefferies Financial Group Inc. from $154.00 to $158.00. The firm currently has a buy rating on the stock.
Nurix Therapeutics (NASDAQ:NRIX) had its price target increased by Needham & Company LLC from $26.00 to $34.00. They currently have a buy rating on the stock.
Bank of N.T. Butterfield & Son (NYSE:NTB) had its target price raised by Wells Fargo & Company from $57.00 to $61.00. The firm currently has an equal weight rating on the stock.
Old Dominion Freight Line (NASDAQ:ODFL) had its price target raised by JPMorgan Chase & Co. from $197.00 to $234.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
PAVmed (NASDAQ:PAVM) had its price target cut by Ascendiant Capital Markets from $65.00 to $56.00. Ascendiant Capital Markets currently has a buy rating on the stock.
Public Storage (NYSE:PSA) had its target price raised by Evercore Inc from $306.00 to $317.00.
Plus Therapeutics (NASDAQ:PSTV) had its target price reduced by Ascendiant Capital Markets from $65.00 to $57.00. Ascendiant Capital Markets currently has a buy rating on the stock.
Rio Tinto Group (LON:RIO) had its target price boosted by Citigroup Inc. from £760 to £810. The firm currently has a neutral rating on the stock.
South32 (LON:S32) had its price target increased by Citigroup Inc. from GBX 3,000 to GBX 3,200. Citigroup Inc. currently has a buy rating on the stock.
Saia (NASDAQ:SAIA) had its price target increased by JPMorgan Chase & Co. from $465.00 to $490.00. They currently have an overweight rating on the stock.
Sportradar Group (NASDAQ:SRAD) had its price target boosted by Needham & Company LLC from $19.00 to $23.00. They currently have a buy rating on the stock.
SSP Group (LON:SSPG) had its target price cut by Citigroup Inc. from GBX 3,600 to GBX 3,200. The firm currently has a buy rating on the stock.
Shattuck Labs (NASDAQ:STTK) had its target price increased by Needham & Company LLC from $14.00 to $17.00. Needham & Company LLC currently has a buy rating on the stock.
Seagate Technology (NASDAQ:STX) had its price target raised by Mizuho from $875.00 to $1,090.00. They currently have an outperform rating on the stock.
Oncology Institute (NASDAQ:TOI) had its target price boosted by BTIG Research from $7.00 to $8.00. The firm currently has a buy rating on the stock.
T. Rowe Price Group (NASDAQ:TROW) had its target price increased by Evercore Inc from $106.00 to $111.00.
Tractor Supply (NASDAQ:TSCO) had its price target lowered by The Goldman Sachs Group, Inc. from $55.00 to $45.00. They currently have a buy rating on the stock.
UnitedHealth Group (NYSE:UNH) had its price target raised by JPMorgan Chase & Co. from $420.00 to $466.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Victoria’s Secret & Co. (NYSE:VSXY) had its target price boosted by JPMorgan Chase & Co. from $77.00 to $88.00. The firm currently has an overweight rating on the stock.
XPO (NYSE:XPO) had its target price boosted by JPMorgan Chase & Co. from $208.00 to $210.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price raised by Cantor Fitzgerald from $24.00 to $34.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Receive News & Ratings for ABM Industries Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABM Industries Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
